10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2016 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 9, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 172,310 | 148,954 | 132,406 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (142,511) | (122,498) | (105,362) |
| Cash paid to other suppliers and employees | (15,550) | (14,162) | (15,344) |
| Interest received | 20 | 21 | 15 |
| Interest paid | (1,140) | (629) | (647) |
| Income taxes paid | (3,060) | (3,274) | (2,931) |
| Net cash provided by operating activities | 10,069 | 8,412 | 8,137 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,224) | (2,367) | (2,136) |
| Proceeds from sale-leaseback transactions | 230 | 411 | 515 |
| Proceeds from sale of property and equipment and other assets | 37 | 35 | 11 |
| Acquisitions (net of cash acquired) and other investments | (539) | (11,475) | (2,439) |
| Purchase of available-for-sale investments | (65) | (267) | (157) |
| Maturity of available-for-sale investments | 91 | 243 | 161 |
| Net cash used in investing activities | (2,470) | (13,420) | (4,045) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 1,874 | (685) | 685 |
| Proceeds from issuance of long-term debt | 3,455 | 14,805 | 1,483 |
| Repayments of long-term debt | (5,943) | (2,902) | (3,100) |
| Purchase of noncontrolling interest in subsidiary | (39) | 0 | 0 |
| Payment of contingent consideration | (26) | (58) | 0 |
| Dividends paid | (1,840) | (1,576) | (1,288) |
| Proceeds from exercise of stock options | 224 | 299 | 421 |
| Excess tax benefits from stock-based compensation | 72 | 127 | 106 |
| Repurchase of common stock | (4,461) | (5,001) | (4,001) |
| Other | (5) | (3) | 0 |
| Net cash (used in) provided by financing activities | (6,689) | 5,006 | (5,694) |
| Effect of exchange rate changes on cash and cash equivalents | 2 | (20) | (6) |
| Net increase (decrease) in cash and cash equivalents | 912 | (22) | (1,608) |
| Cash and cash equivalents at the beginning of the year | 2,459 | 2,481 | |
| Cash and cash equivalents at the end of the year | 3,371 | 2,459 | 2,481 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 5,319 | 5,239 | 4,644 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,475 | 2,092 | 1,931 |
| Stock-based compensation | 222 | 230 | 165 |
| Loss on early extinguishment of debt | 643 | 0 | 521 |
| Deferred income taxes and other noncash items | 153 | (266) | (58) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (243) | (1,594) | (737) |
| Inventories | (742) | (1,141) | (770) |
| Other current assets | 35 | 355 | (383) |
| Other assets | (43) | 2 | 9 |
| Accounts payable and claims and discounts payable | 2,189 | 2,834 | 1,742 |
| Accrued expenses | 59 | 765 | 1,060 |
| Other long-term liabilities | 2 | (104) | 13 |
| Net cash provided by operating activities | 10,069 | 8,412 | 8,137 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |